NeoGenomics (NASDAQ:NEO) Trading Down 7.7% After Analyst Downgrade

Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) were down 7.7% on Tuesday after Needham & Company LLC lowered their price target on the stock from $24.00 to $19.00. Needham & Company LLC currently has a buy rating on the stock. NeoGenomics traded as low as $13.70 and last traded at $14.05. Approximately 252,873 […]

Related Keywords

United Kingdom ,United States ,Piper Sandler ,Banque Cantonale Vaudoise ,William Blair ,Aliciac Olivo ,Needham Company ,Securities Exchange Commission ,Oak Family Advisors ,First Light Asset Management ,Allspring Global Investments Holdings ,Goldman Sachs Group ,Financial Services Group Inc ,Clinical Services ,Nasdaq ,Neogenomics Inc ,Get Free Report ,General Counsel Alicia ,Exchange Commission ,Global Investments Holdings ,Family Advisors ,Cantonale Vaudoise ,Services Group ,Light Asset Management ,Genomics Trading Down ,Advanced Diagnostics ,Neogenomics Daily ,